Innovative Cosmeceuticals: Sirtuin Activators and Anti-Glycation Compounds

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 3, 2011, Pages 163-166

  Farris, Patricia K ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopeptides; Collagen; Elastin; Glycation; Photoaging; Resveratrol

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COSMETIC; SIRTUIN;

CUTANEOUS PARAMETERS; DIET RESTRICTION; GLYCATION; PHOTOAGING; REVIEW; SKIN PIGMENTATION; TELANGIECTASIA;

ANTIOXIDANTS; COSMETICS; ENZYME ACTIVATORS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PLANT PREPARATIONS; SIRTUINS; SKIN AGING; STILBENES;

EID: 80052977503     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2011.05.004     Document Type: Review

References (53)

1. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993, 90:7915-7922.
2. Pinnell S.R. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 2003, 48:1-19.
3. Muller F.L., Lustgarten M.S., Jang Y., et al. Trends in oxidative aging theories. Free Radic Biol Med 2007, 43:477-503.
4. Masaki H. Role of antioxidants in the skin: Anti-aging effects. J Dermatol Sci 2010, 58:58-90.
5. Darr D., Dunston S., Faust H., et al. Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol 1996, 76:264-268.
6. Mukhtar A.F. Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp Dermatol 2006, 15:678-684.
7. Camougrand N., Rigoulet M. Aging and oxidative stress: Studies of some genes involved both in aging and in response to oxidative stress. Respir Physiol 2001, 128:393-401.
8. Robinson M.K., Binder R.L., Griffiths C.E. Genomic-driven insights into changes in aging skin. J Drugs Dermatol 2009, 8:s8-s11.
9. Lin SJ, Defossez PA, Guarente L: Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289:2126-2128.
10. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004, 73:417-435.
11. Vaziri H., Dessain S.K., Ng Eaton E., et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
12. Nemoto S., Fergusson M.M., Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 2005, 280:16456-16460.
13. van der Horst A., Tertoolen L.G., de Vries-Smits L.M., et al. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 2004, 279:28873-28879.
14. Imai S., Sirtuins G.L. A universal link between NAD, metabolism and aging. The Molecular Biology of Aging 2007, 39-72. Cold Spring Habor Laboratory, New York. L. Guarente, W.D. Patridge (Eds.).
15. Dali-Youcef N., Lagouge M., Froelich S., et al. The "magnificent seven": Function, metabolism and longevity. Ann Med 2007, 39:335-345.
16. Michan S., Sinclair D. Sirtuins in mammals: Insights into their biological function. Biochem J 2007, 404:1-13.
17. Ingram D.K., Zhu M., Mamczarz J., et al. Calorie restriction mimetics: An emerging research field. Aging Cell 2006, 5:97-108.
18. Howitz K.T., Bitterman K.J., Cohen H.Y., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
19. Barger J.L., Kayo T., Vann J.M., et al. A low dose of dietary resveratrol partially mimics calorie restriction and retards aging parameters in mice. PloS ONE 2009, 3:e2264.
20. Baur J.A., Pearson K.J., Price N.L., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
21. Lagouge M., Argmann C., Gerhart-Hines Z., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
22. Baur J.A. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010, 131:261-269.
23. Marques F.Z., Markus M.A., Morris B.J. Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biochem Cell Biol 2009, 41:2125-2128.
24. Jang M., Cai L., Udeani G.O., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
25. Aziz M.H., Reagan-Shaw S., Wu J., et al. Chemoprevention of skin cancer by grape constituent resveratrol: Relevance to human disease?. FASEB J 2005, 19:1193-1195.
26. Clément M.V., Hirpara J.L., Chawdhury S.H., et al. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92:996-1002.
27. Huang C., Ma W.Y., Goranson A., et al. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogensis 1999, 20:237-242.
28. Kundu J.K., Shin Y.K., Surh Y.J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol 2006, 72:1506-1515.
29. Ohguchi K., Itoh T., Akao Y., et al. SIRT1 modulates expression of matrix metalloproteinases in human dermal fibroblasts. Br J Dermatol 2010, 162:689-694.
30. Baxter R.A. Anti-aging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation. J Cosmet Dermatol 2008, 7:2-7.
31. Jagdeo J., Adams L., Lev-Tob H., et al. Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro. J Drugs Dermatol 2010, 12:1523-1526.
32. Calabrese G. Nonalcoholic compounds of wine: The phytoestrogen resveratrol and moderate red wine consumption during menopause. Drugs Exp Clin Res 1999, 25:111-114.
33. Gehm B.D., McAndrews J.M., Chien P.Y., et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 1997, 94:14138-14143.
34. Su J.L., Yang C.Y., Zhao M., et al. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem 2007, 282:19385-19398.
35. Castelo-Branco C., Duran M., González-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas 1992, 15:113-119.
36. Smith J.J., Kenney Rd, Gagne D.J., et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC. Syst Biol 2009, 3:31.
37. Moreau M., Neveu M., Stephan S., et al. Enhancing cell longevity for cosmetic application: A complementary approach. J Drugs Dermatol 6 Suppl 2007, 14-18.
38. Urbach E., Lentz J.W. Carbohydrate metabolism and skin. Arch Dermatol Syph 1945, 52:301-316.
39. Méndez J.D., Xie J., Aguilar-Hernández M., et al. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases. Mol Cell Biochem 2010, 344:185-193.
40. Chace K.V., Carubelli R., Nordquist R.E. The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates. Arch Biochem Biophys 1991, 288:473-480.
41. Hujiberts M.S., Schaper N.C., Schalkwijk C.G. Advanced glycation end products and diabetic foot disease. Diabetes/Metab Res Rev 2008, 24(Suppl 1):S19-S24.
42. Corstjens H., Dicanio D., Muizzuddin N., et al. Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects. Exp Gerontol 2008, 43:663-667.
43. Yamauchi M., Prisayanh P., Haque Z., et al. Collagen cross-linking in sun-exposed and unexposed sites of aged human skin. J Invest Dermatol 1991, 97:938-941.
44. O'Brien J., Morrissey P.A. Nutritional and toxicological aspects of the Maillard Browning reaction in foods. Crit Rev Food Sci Nutr 1989, 28:211-248.
45. Tuohy K.M., Hinton D.J., Davies S.J., et al. Metabolism of Maillard reaction products by the human gut microbiota--implications for health. Mol Nutr Food Res 2006, 50:847-857.
46. Takagi Y., Kashiwagi A., Tanaka Y., et al. Significance of fructose-induced protein oxidation and formation of advanced glycation end product. J Diabetes Complications 1995, 9:87-91.
47. Dearlove R.P., Greenspan P., Hartle D.K., et al. Inhibition of protein glycation by extracts of culinary herbs and spices. J Med Food 2008, 11:275-281.
48. Mcintyre K.L., Harris C.S., Saleem A., et al. Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med 2009, 75:286-292.
49. Wu C.H., Yen G.C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation end products. J Agric Food Chem 2005, 53:167-173.
50. Thirunavukkarasu V., Nandhini A.T., Anuradha C.V. Fructose diet-induced skin collagen abnormalities are prevented by lipoic acid. Exp Diabesity Res 2004, 5:237-244.
51. Danby F.W. Nutrition and aging skin: Sugar and glycation. Clin Dermatol 2010, 28:409-411.
52. Furber J.D. Extracellular glycation crosslinks: Prospects for removal. Rejuvenation Res 2006, 9:274-278.
53. Draelos Z.D., Yatskayer M.S., Raab S., et al. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin. J Cosmet Dermatol 2009, 8:147-151.